{"entity":{"type":"insider","cik":"0001822619","url":"/insider/0001822619","json_url":"/insider/0001822619.json","name":"Ouimette Mike","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":9,"first":"2022-12-21","last":"2025-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Ouimette Mike","source":"filing","n_filings":9,"first_seen":"2022-12-21","last_seen":"2025-01-22"}],"transactions":[{"id":4560124,"accession":"0001746473-25-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001746473-25-000001","line_url":"/filing/0001746473-25-000001#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10230.0,"shares_display":"10,230","price_per_share":10.9934,"price_display":"10.99","price_state":"stated","total_value":112462.482,"total_display":"112,462.48","total_whole":"112,462","shares_owned_after":70544.0,"shares_owned_after_display":"70,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-22","scope":"insider"},{"id":4560119,"accession":"0001746473-25-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-25-000001","line_url":"/filing/0001746473-25-000001#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13270.0,"shares_display":"13,270","price_per_share":11.2011,"price_display":"11.20","price_state":"stated","total_value":148638.597,"total_display":"148,638.60","total_whole":"148,639","shares_owned_after":80774.0,"shares_owned_after_display":"80,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-22","scope":"insider"},{"id":3101056,"accession":"0001746473-24-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000121","line_url":"/filing/0001746473-24-000121#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7656.0,"shares_display":"7,656","price_per_share":11.56,"price_display":"11.56","price_state":"stated","total_value":88503.36,"total_display":"88,503.36","total_whole":"88,503","shares_owned_after":94044.0,"shares_owned_after_display":"94,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":2873496,"accession":"0001746473-24-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001746473-24-000001","line_url":"/filing/0001746473-24-000001#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5197.0,"shares_display":"5,197","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":89544.31,"total_display":"89,544.31","total_whole":"89,544","shares_owned_after":55246.0,"shares_owned_after_display":"55,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":7870913,"accession":"0001209191-23-043085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043085","line_url":"/filing/0001209191-23-043085#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4755.0,"shares_display":"4,755","price_per_share":17.55,"price_display":"17.55","price_state":"stated","total_value":83450.25,"total_display":"83,450.25","total_whole":"83,450","shares_owned_after":60443.0,"shares_owned_after_display":"60,443","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-21","scope":"insider"},{"id":8043506,"accession":"0001209191-23-042834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042834","line_url":"/filing/0001209191-23-042834#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12778.0,"shares_display":"12,778","price_per_share":18.0091,"price_display":"18.01","price_state":"stated","total_value":230120.2798,"total_display":"230,120.28","total_whole":"230,120","shares_owned_after":65198.0,"shares_owned_after_display":"65,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8652197,"accession":"0001209191-23-022376","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-022376","line_url":"/filing/0001209191-23-022376","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2877.0,"shares_display":"2,877","price_per_share":26.78700615224192,"price_display":"26.79","price_state":"stated","total_value":77066.2167,"total_display":"77,066.22","total_whole":"77,066","shares_owned_after":50989.0,"shares_owned_after_display":"50,989","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-03","scope":"insider","n_lines":2},{"id":8652192,"accession":"0001209191-23-022376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-022376","line_url":"/filing/0001209191-23-022376#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4874.0,"shares_display":"4,874","price_per_share":26.5209,"price_display":"26.52","price_state":"stated","total_value":129262.8666,"total_display":"129,262.87","total_whole":"129,263","shares_owned_after":53666.0,"shares_owned_after_display":"53,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-30","filed_date":"2023-04-03","scope":"insider"},{"id":8731076,"accession":"0001140361-23-002785","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-23-002785","line_url":"/filing/0001140361-23-002785#line-3","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":34.1939,"price_display":"34.19","price_state":"stated","total_value":683878.0,"total_display":"683,878.00","total_whole":"683,878","shares_owned_after":5947.0,"shares_owned_after_display":"5,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":6175511,"accession":"0001140361-22-046917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-046917","line_url":"/filing/0001140361-22-046917#line-1","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2928.0,"shares_display":"2,928","price_per_share":19.3753,"price_display":"19.38","price_state":"stated","total_value":56730.8784,"total_display":"56,730.88","total_whole":"56,731","shares_owned_after":5947.0,"shares_owned_after_display":"5,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-23","scope":"insider"},{"id":6175504,"accession":"0001140361-22-046568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-046568","line_url":"/filing/0001140361-22-046568#line-2","is_derivative":false,"issuer_cik":"0001746473","issuer_name":"PLIANT THERAPEUTICS, INC.","issuer_ticker":"PLRX","issuer_name_source":null,"issuer_url":"/issuer/0001746473","owner_cik":"0001822619","owner_name":"Ouimette Mike","owner_display_name":"Ouimette Mike","owner_url":"/insider/0001822619","role":"Officer (General Counsel & Corp. Sec'y)","role_mark":"O","role_mark_label":"Officer (General Counsel & Corp. Sec'y)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Corp. Sec'y","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4719.0,"shares_display":"4,719","price_per_share":19.1024,"price_display":"19.10","price_state":"stated","total_value":90144.2256,"total_display":"90,144.23","total_whole":"90,144","shares_owned_after":8875.0,"shares_owned_after_display":"8,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001746473","name":"PLIANT THERAPEUTICS, INC.","url":"/issuer/0001746473","role":"Officer (General Counsel & Corp. Sec'y)","n_filings":9,"first_seen":"2022-12-21","last_seen":"2025-01-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001822619","retrieved_at":"2026-08-25T07:02:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}